Healthcare

Content for the Healthcare industry

  • April 2020 Clinical Watch Newsletter

    April 2020 Clinical Watch Newsletter

    In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associated with COVID-19 treatment and suggest prior authorization criteria for the first approved tre

    Learn More
  • March 2020 Clinical Watch Newsletter

    March 2020 Clinical Watch Newsletter

    In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug.

    Learn More
  • Overcoming Payer Barriers through  the Three Pillars of Hub Onboarding: Rate, Time, Duration

    Overcoming Payer Barriers through the Three Pillars of Hub Onboarding: Rate, Time, Duration

    Pharmaceutical manufacturers and payers are often at odds over pricing and barriers to new medication access. Payers will typically initiate a variety of cost containment initiatives,

    Learn More
  • February 2020 Clinical Watch Newsletter

    February 2020 Clinical Watch Newsletter

    In this issue of Clinical Watch, we discuss COVID-19 and suggest prior authorization criteria for immunotherapy to reduce the severity of allergic reactions to peanuts.

    Learn More
  • January 2020 Clinical Watch Newsletter

    January 2020 Clinical Watch Newsletter

    Learn More
  • Using Augmented Reality to Influence Better Patient Outcomes

    Using Augmented Reality to Influence Better Patient Outcomes

    Augmented Reality enables the physical environment or object to become a digital portal to relevant, personalized information that can be tailored to inform users...

    Learn More
  • Modernizing Outbound Communication Print and Digital Processes for Business Efficiency

    Modernizing Outbound Communication Print and Digital Processes for Business Efficiency

    Learn More
  • Clinical Watch: August 2019

    Clinical Watch: August 2019

    In this issue of Clinical Watch, we discuss the expanded indication for drugs to treat relapsing forms of multiple sclerosis.

    Learn More
  • Hub Collaboration: Igniting Efficiency for Patient Assistance Programs

    Hub Collaboration: Igniting Efficiency for Patient Assistance Programs

    Yet the process of getting patients going on medications through a PAP is often slowed or inhibited by the information-gathering process...

    Learn More
  • Transforming Pharma Field Sales Requires Digitally Empowered Teams

    Transforming Pharma Field Sales Requires Digitally Empowered Teams

    Big data has the ability to transform pharma field sales — if pharma manufacturers can translate data into actionable insights and real-time outreach at the individual territory level.

    Learn More
  • Telemedicine offers new strategies to improve Medicaid programs

    Telemedicine offers new strategies to improve Medicaid programs

    Telemedicine offers new strategies to improve Medicaid programs

    Learn More
  • Recovery Month, Grant Applications, and Building Resources for Recovery

    Recovery Month, Grant Applications, and Building Resources for Recovery

    Learn More
  • Clinical Watch: June 2019

    Clinical Watch: June 2019

    In this issue of Clinical Watch, we discuss the FDA guidance on biosimilar interchangeability.

    Learn More
  • Conduent’s Recent Leadership Recognition by NelsonHall Makes a Statement: Here’s Why

    Conduent’s Recent Leadership Recognition by NelsonHall Makes a Statement: Here’s Why

    In a recent press release, Conduent announced it was named an overall leader in NelsonHall’s Advanced Analytics NEAT Rankings across multiple industries, including healthcare.

    Learn More
  • Conduent HSP Payer Suite Earns Leadership Ranking in NelsonHall’s Healthcare Commercial Payer BPS Report

    Conduent HSP Payer Suite Earns Leadership Ranking in NelsonHall’s Healthcare Commercial Payer BPS Report

    Conduent was recognized as a leader in the NelsonHall Healthcare Commercial Payer BPS report, which examines BPS activities associated with healthcare insurance in the commercial sector in the United

    Learn More
  • Clinical Watch: May 2019

    Clinical Watch: May 2019

    In this issue of Clinical Watch, we discuss the evolution of psoriasis treatment. We suggest criteria for a new biologic for plaque psoriasis and review the albumin-lowering effect of dapagliflozin.

    Learn More
  • Three Ways Hospitals can Use Data to Achieve and Sustain Quality Improvement

    Three Ways Hospitals can Use Data to Achieve and Sustain Quality Improvement

    How do you measure quality in healthcare? It's a question that is top of mind in an industry where quality is both expected and difficult to define.

    Learn More
  • Patient-Focused Drug Development (PFDD) — the FDA Guidance that Changes How Life Sciences Works

    Patient-Focused Drug Development (PFDD) — the FDA Guidance that Changes How Life Sciences Works

    The FDA is encouraging the industry to include patients in a meaningful way in drug development — from pre-IND through commercialization.

    Learn More
  • Conduent Regulatory Bulletin 2019 - Issue 1

    Conduent Regulatory Bulletin 2019 - Issue 1

    Learn More
  • Why Conduent for Government Eligibility Services?

    Why Conduent for Government Eligibility Services?

    Learn More
  • loading
    Loading More...